Manchin and Braun Call on HHS To Take Immediate Action Against Drug Manufacturers in Contract Pharmacy Battle

Senators Manchin (D-WV) and Braun (R-Ind.) are urging HHS to take action against drug manufacturers who have placed restrictions in the contract pharmacy setting.

Government health officials need to take immediate action to fully enforce the law against drug makers who are denying 340B drug discounts to providers who use contract pharmacies to dispense 340B-priced drugs, U.S. Senator Joe Manchin (D-W.VA.) and U.S. Senator

Read More »

Generic/OTC Drug Maker Owes Refunds to 340B Providers, HRSA Audit Shows

HRSA released findings from its audit of drug company VistaPharm.

The U.S. Health Resources Services Administration (HRSA) has ordered South Carolina-based VistaPharm, a manufacturer of generic and over-the-counter (OTC) drugs to repay overcharges to 340B covered entities after a HRSA audit showed the company did not offer its products at the

Read More »

New York Times Front Page Story on 340B Program Causes Shockwaves

The New York Times weekend front page story on Bon Secours Mercy Health System’s alleged misuse of the 340B program is creating a stir in the 340B community.

340B stakeholders are responding to a long investigative article in Saturday’s New York Times that accuses a Catholic health system of exploiting the 340B discount program at the expense of one of its inner-city hospitals to enrich its other hospitals

Read More »

New Rule Gives Force to Ground-Breaking State 340B Contract Pharmacy Law

Arkansas Insurance Department
Arkansas has published a regulation that gives force to the state’s ground-breaking 340B contract pharmacy law.

The Arkansas Insurance Department (AID) published a rule this week that gives force to the state’s ground-breaking 2021 law prohibiting drug makers from denying 340B pricing or restricting access to drugs when covered entities contract with pharmacies to

Read More »

HRSA Grants 340B Enrollment Flexibility in Puerto Rico Due to Hurricane

Puerto Rico, Hurricane Fiona, Pedro Pierluisi
Puerto Rico Gov. Pedro Pierluisi (D) (second from right), FEMA officials, and local residents assessed damage yesterday from Hurricane Fiona.

The U.S. Health Resources and Services Administration (HRSA) is letting eligible healthcare providers in Puerto Rico enroll in the 340B program immediately in light of Hurricane Fiona.

Please Login or Become a Paid Subscriber to View

Read More »

CMS Gets Conflicting Advice About Unwinding Drug Payment Cuts for 340B Hospitals

outpatient
Stakeholders offered CMS conflicting advice about how to reverse a nearly 30% cut in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs since 2018. | Flickr.com/photos/rxb

340B stakeholders have offered federal healthcare officials conflicting advice about how best to respond to the U.S. Supreme Court’s June decision striking down a nearly 30% cut in Medicare Part B drug reimbursement for hospitals’ 340B-purchased drugs.

Read More »

Unichem Says 340B Audit Found it Overcharged Just Two Entities and Must Repay Them Just $110.20

Drug manufacturer Unichem said a HRSA 340B compliance audit found that it overcharged just two facilities and must repay them just $110.20.
Generic drug manufacturer Unichem says a 340B compliance audit found it overcharged just two entities and the repayment to both totals just $110.20.

Generic drug manufacturer Unichem says a 340B compliance audit found it overcharged only two entities and the repayment to both totals just $110.20.

Please Login or Become a Paid Subscriber to View this Content

Read More »

Comments Due Today on How Feds Should Rectify Drug Payment Cuts for 340B Hospitals

September 2022
Today is the deadline for public comments on Medicare’s proposed rule for how it will pay for hospital outpatient services and clinician-administered drugs in 2023.

Today is the deadline for public comments on Medicare’s proposed rule for how it will pay for hospital outpatient services and clinician-administered drugs in 2023.

Please Login or Become a Paid Subscriber to View

Read More »

Restoring 340B Hospitals’ Part B Drug Payments Would Cut Net Outpatient Payments for 80% of Hospitals, Private Cancer Doctor-Funded Study Finds

Hospital, outpatient, Medicare, prescription drug
80% of hospitals in Medicare’s outpatient prospective payment system would see their net payments decline next year if CMS ends a nearly 30% cut in 340B hospitals’ drug payments, according to a private oncologist group funded study.

Eighty percent of all hospitals in Medicare’s outpatient prospective payment system—including 52% of all 340B hospitals—would see their net OPPS payments decline next year if Medicare ends a nearly 30% cut in 340B hospitals’ drug payments that began

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report